Drive DeVilbiss Healthcare CPAP Devices   – Class Action Investigation

Chimicles Schwartz Kriner & Donaldson-Smith is investigating a potential class action case related to reports that certain CPAP devices manufactured by Drive DeVilbiss Healthcare contain the same polyester-based polyurethane foam material used in the Philips CPAP units that can cause injuries which can be life-threatening, cause permanent impairment, and/or require medical intervention to preclude permanent impairment. This foam material tends to degrade into particles and emit volatile toxic compounds, including formaldehyde, into the mouth and nose of users.

DeVilbiss discontinued the production of their DV5 CPAP units in August 2021, a few months following the massive recall of the Philips CPAP units.  On June 29, 2021, DeVilbiss issued a statement conceding that their machines contained polyester-based polyurethane foam, though the Company declined to launch a voluntary recall because they had not seen any reports of any adverse health conditions caused by the machines.

The FDA has received numerous complaints from users of these CPAP machines of foam degradation including black particles being found in the machines, including in the air pathway.  The Company has yet to send out any public notification disclosing the serious health risks associated with the material used in these machines.

If you currently used or have used a DV5 CPAP, please fill-out the form provided below.